SLN today

$19.84+$0.04 (+0.18%)close Nov 13, 2026

Trend

DailyDowntrend (starting)

4 hourStrong Bullish

1 hourAscending Triangle

15 minBullish

5 minBullish

Daily trend turns up above $17.58

Key levels

Resistance$21.04

Resistance$20.48

Support$19.65

Support$18.95

About Silence Therapeutics

Silence Therapeutics is a biotechnology company that discovers and develops siRNA molecules to silence specific genes involved in disease. Its pipeline targets rare blood disorders, cardiometabolic conditions, and other diseases with unmet need, using its mRNAi GOLD platform for liver delivery. The company operates in the United States, United Kingdom, and Europe, and collaborates with partners such as AstraZeneca.

Based on the company's 10-K filed Mar 5, 2026.

Nasdaq · Healthcare

Silence Therapeutics plc (SLN)

$19.84+0.04 (+0.18%)

WATCHLISTGrade: C+Risk: MEDIUM

1D 5D1M1Y 5Y MaxSign up for all timeframes

High19.86

Low19.76

Open19.78

Volume496K

Avg Vol3.28M

VWAP19.80

30d High19.84

30d Low8.68

30d Chg+95.61%

See full chart with real-time data

What Is the Price Target for SLN?

SEPT Low Target

$20.00

SEPT Mid Target

$32.00

SEPT High Target

$75.00

Analyst Consensus

$32.00

Current: $19.80Upside: +61.6%Confidence: 65%Method: Analyst Consensus

Is SLN a Buy or Sell Right Now?

Investability Score

WATCHLIST12-18 months

News summary · last 30 days

Nov 12▼ DownEarnings3 articles

Silence Therapeutics reported its Q3 2026 financials, posting a quarterly loss of $0.24 per share, which was wider than the $0.12 loss analysts had expected. The company also filed a Form 8-K disclosing a major event, though details were not specified. Despite the earnings miss, the stock closed slightly higher at $19.80, up 0.20% on the day. The wider-than-expected loss is a bearish signal, but the muted price reaction suggests the market may have already priced in the miss or is awaiting further details from the 8-K filing.

Oct 19▲ UpMergerProduct3 articles

Silence Therapeutics shares closed at $19.58, down a marginal 0.03% from the open of $19.59, trading in a tight range between $19.56 and $19.61 on heavy volume of 46.8 million shares. The muted price action follows news that Merck KGaA will acquire the company for $1.1 billion in cash, with ADS holders set to receive $20 per share. That $20 buyout price sits just above today's close, suggesting the market is pricing the deal as highly likely to close. The direction signal is bullish given the confirmed all-cash merger agreement.

Thesis

•Revenue growing -98.7% YoY with DECLINING trend — consistent growth.

AI-Powered Trading Signals

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for SLN.

Start Free Trial →

Is SLN Overvalued or Undervalued?

Valuation Verdict

UNDERVALUED

Methods Used

Analyst Consensus

Fair Value

$32.00

Moat Score

NONE

1/9

Piotroski Score

17.0

Altman Z-Score

What Is Smart Money Doing with SLN?

Insider Signal

NEUTRAL

2 buys / 2 sells (90d)

Congress Signal

NEUTRAL

0 buys / 0 sells (90d)

Institutional

N/A

Short Squeeze Risk

HIGH

Signal: HIGH_SHORT_INTEREST

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See All Smart Money Signals →

SLN Growth Story

Revenue YoY

-98.7%

3yr Revenue CAGR

-70.5%

EPS Growth YoY

-90.91%

FCF Growth YoY

8.1%

Revenue Trend

DECLINING

Dark Pool Trades for SLN

PREVIEW

SEPT Investing tracks real-time dark pool institutional trades for SLN, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.

Time	Price	Size	Value	Side
20:33:08	$19.83	1,000	$$20K	SELL
20:31:05	$19.84	1,918	$$38K	MIDPOINT
19:57:54	$19.84	1,000	$$20K	MIDPOINT
19:57:54	$19.84	1,000	$$20K	MIDPOINT
19:57:54	$19.84	1,000	$$20K	MIDPOINT

5 dark pool trades shown · $$117K preview volume

Real-time institutional flow, block trades, and net positioning

See all dark pool activity

Options Flow for SLN

PREVIEW

SEPT Investing provides real-time options flow tracking for SLN, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.

Type	Strike	Expiry	DTE	Premium	Size	Trade
CALL	$20	Apr 16	154	$$10	1	SWEEP
CALL	$20	Apr 16	154	$$20	2	SWEEP
CALL	$20	Apr 16	154	$$10	1	SWEEP
CALL	$20	Apr 16	154	$$750	75	SWEEP
CALL	$20	Apr 16	154	$$10	1	SWEEP

5 options trades shown · 100% calls

Unusual activity, GEX levels, max pain, and dealer positioning

See full options flow

What Traders Are Saying About SLN

1 posts

SEPT Investing hosts an active community of 3,500+ traders sharing real-time analysis, trade setups, and market discussion for SLN. Join verified traders discussing price action, dark pool alerts, options flow, and AI-powered market intelligence.

Rebecca Watanabe12h ago

invus global management and affiliated entities filed an amended schedule 13g/a on thu nov 12, reporting beneficial ownership of approximately 4.6% of silence therapeutics plc's ordinary shares as of ...

21 views

Join 3,500+ traders discussing SLN in real-time

Trade ideas, setups, dark pool alerts, and AI-powered analysis

Join the discussion

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for Silence Therapeutics plc (SLN) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (3 articles analyzed), and SEC filing intelligence...

AI-Powered Trading Signals.

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.

Try SEPT Free for 7 Days →

SLN — frequently asked questions

What is SLN stock price today?

Silence Therapeutics plc (SLN) is at $19.84, up 0.18% (+$0.04) at the Nov 13, 2026 close.

Why is SLN stock up today?

Nov 12, 2026: Silence Therapeutics reported its Q3 2026 financials, posting a quarterly loss of $0.24 per share, which was wider than the $0.12 loss analysts had expected. The company also filed a Form 8-K disclosing a major event, though details were not specified.

What is the SLN price target?

The average analyst price target for SLN is $32.00, ranging from $20 to $75, based on 3 analysts. Latest: HC Wainwright & Co. downgrade on Oct 21, 2026.

What do analysts rate SLN?

Analyst ratings for SLN: 0 Buy, 4 Hold, 1 Sell — consensus Hold.

Did SLN beat earnings?

SLN last reported on Nov 12, 2026: EPS -$0.24 vs -$0.12 expected — a miss of 100.0%.

Does SLN pay a dividend?

SLN does not currently pay a dividend.

What are SLN support and resistance levels?

Support: $19.65, $18.95, $18.29. Resistance: $20.48, $21.04, $21.80.

What are insiders doing with SLN?

Insider activity: NEUTRAL, 2 buys and 2 sells in the last 90 days.

What is the latest news on SLN?

Nov 12, 2026: Silence Therapeutics Posts Q3 2026 Financials · Nov 12, 2026: Silence Therapeutics posts quarterly loss of $0.24 per share, wider than $0.12 expected · Nov 12, 2026: Silence Therapeutics plc filed a report on a major company event (Form 8-K)